Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, kidney cancer, kidney disorder, neoplasm, urinary system disorderActive, not recruitingPhase 22026-08-12NCT03203473

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bristol-Myers Squibb422
Toni Choueiri, MD1

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beth Israel Deaconess Medical CenterBostonUnited States45
Dana Farber Cancer InstituteBostonUnited States133
Lifespan Comprehensve Cancer CenterProvidenceUnited States1
University of California, San Diego Moores Cancer CenterLa JollaUnited States5
University of Chicago Medical CenterChicagoUnited States152
University of North Carolina at Chapel HillChapel HillUnited States129
University of Utah, Huntsman Cancer CenterSalt Lake CityUnited States3
Unviersity of Wisconsin Carbone Cancer CenterMadisonUnited States1